| RS2107651195 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Intellectual developmental disorder |
| RS2107651275 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107651297 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2107651375 |
ACAD9
|
Health Risk |
Likely pathogenic |
— |
| RS2107651486 |
CASR
|
Health Risk |
Pathogenic |
— |
| RS2107651620 |
SETD2
|
Health Risk |
Pathogenic |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS2107651840 |
SETD2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2107651962 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2107653861 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107654116 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107654130 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107655510 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107656502 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107657132 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107657268 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107657717 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107657797 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, Mitochondrial complex I deficiency |
| RS2107657800 |
ACAD9
|
Health Risk |
Likely pathogenic |
— |
| RS2107658582 |
ADCY5
|
Health Risk |
Pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS2107658703 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107658867 |
ADCY5
|
Health Risk |
Likely pathogenic |
— |
| RS2107659422 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107659507 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2107659593 |
ACAD9
|
Health Risk |
Pathogenic |
— |
| RS2107659720 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107659875 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107659888 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa |
| RS2107660525 |
COL7A1
|
Health Risk |
Likely pathogenic |
Generalized dominant dystrophic epidermolysis bullosa, COL7A1-related disorder |
| RS2107660536 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107661371 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107661505 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Pretibial dystrophic epidermolysis bullosa |
| RS2107661511 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107662258 |
COL7A1
|
Health Risk |
Likely pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS2107662598 |
ACAD9
|
Health Risk |
Likely pathogenic |
— |
| RS2107663241 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107663986 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2107664575 |
ACAD9
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS2107665131 |
COL7A1
|
Health Risk |
Likely pathogenic |
Transient bullous dermolysis of the newborn, Transient bullous dermolysis of the newborn |
| RS2107667545 |
COL7A1
|
Health Risk |
Likely pathogenic |
Abnormality of the skin, Abnormality of the skin |
| RS2107667819 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107667915 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668010 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668041 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668072 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668094 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668103 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668104 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS2107668121 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668482 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107668551 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668560 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668566 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668582 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668584 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668588 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668593 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668601 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668602 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668617 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668634 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668638 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668641 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668647 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668655 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668679 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668680 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS2107668687 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS2107668693 |
GATA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668699 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS2107668704 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS2107668727 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668733 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668739 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668749 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668760 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668769 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668773 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668788 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668794 |
GATA2
|
Health Risk |
Likely pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668805 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668806 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668812 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668823 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668827 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668832 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668848 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668860 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668869 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107668943 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107669589 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2107669831 |
COL7A1
|
Health Risk |
Likely pathogenic |
7 conditions, 7 conditions |
| RS2107670113 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107670284 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2107670301 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670326 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS2107670328 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670331 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670346 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670366 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS2107670386 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |